8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane
C23H27F2N3O — CID 158061811
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane
8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane (PubChem CID 158061811) has the molecular formula C23H27F2N3O and a molecular weight of 399.49 g/mol. Its IUPAC name is 8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane.
Molecular Properties
| Compound Name | 8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane |
|---|---|
| PubChem CID | 158061811 |
| Molecular Formula | C23H27F2N3O |
| Molecular Weight | 399.49 g/mol |
| Exact Mass | 399.21 |
| IUPAC Name | 8-[(1S,3R,5S)-3-[3-(2,2-difluorocyclopropyl)-2-oxopropyl]-5-methylcyclohexyl]quinoxaline-5-carbonitrile;methane |
| SMILES | C.C[C@H]1C[C@@H](CC(=O)CC2CC2(F)F)C[C@@H](c2ccc(C#N)c3nccnc23)C1 |
| InChI | InChI=1S/C22H23F2N3O.CH4/c1-13-6-14(9-18(28)10-17-11-22(17,23)24)8-16(7-13)19-3-2-15(12-25)20-21(19)27-5-4-26-20;/h2-5,13-14,16-17H,6-11H2,1H3;1H4/t13-,14+,16-,17?;/m0./s1 |
| InChIKey | FKSXFTFRVHBNCW-IWLWVRKHSA-N |
| XLogP | 5.66 |
| TPSA | 66.64 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 399.49 |
| LogP ≤ 5 | 5.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158061811 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.